Cardio Blogger

Atrial Failure as a Clinical Entity

12 January 2024

Atrial Failure as a Clinical Entity (published JACC January 2020)

(i) Definition of Atrial Failure

 “Any atrial dysfunction (anatomical, mechanical, electrical, and/or rheological, including blood homeostasis) causing impaired heart performance and symptoms, and worsening quality of life or life expectancy, in the absence of significant valvular or ventricular abnormalities.”

(ii) Causes

  1. Atrial rhythm disorders
  2. Atrial Cardiomyopathy
  3. Atrial remodelling
A. Electrical Dyssynchrony
• AV dyssynchrony
 Left bundle branch block
First-degree AV block
Suboptimal pacemaker programming
• Atrial dyssynchrony
Advanced interatrial block
Slow intra-atrial conduction velocities
B. Booster-Pump and Reservoir Dysfunction
• Fast/disorganized atrial activation
 Atrial fibrillation
Focal/reentrant atrial tachycardia
• Extensive atrial fibrosis 
Advanced atrial remodeling
 Extensive post-ablation scarring
 Atrial infarction
Atrial cardiomyopathy
C. Impaired Conduit Function
• Severe atrial dilation
• Spherical atrial deformation
• Altered transmitral pressure gradient

(iii) Mechanisms and Manifestations of Atrial Failure

  1. Atrial failure and risk of thromboembolic events

2. Atrial and ventricular interaction in HF

Worsening of heat failure symptoms

Stroke

Pulmonary artery hypertension

3. Extra-Atrial Consequences of Atrial Failure

Tachycardia-induced cardiomyopathy

Increased risk of HF and sudden cardiac death

Ventricular ischemia and type 2 myocardial infarction

Atrial functional mitral and tricuspid regurgitation

(iv) Potential Intervention

Areas of ImpactPotential Future Interventions
Risk of strokeOAC might be indicated in individuals without AF
or discouraged in patients with AF
Upstream therapy to reduce fibrosis/thrombotic
milieu
Heart failureTailored HF treatment
Upstream therapy to reduce fibrosis
Interventions to reduce MR
Left atrial pacing
AF managementTailored ablation approach (substrate-based vs.
pulmonary vein isolation)
Selection of candidates for rhythm or rate control
DyssynchronyLeft atrial or bi-atrial pacing
Extra-atrial involvementSudden death risk stratification
OAC indicated in advanced atrial failure to
prevent embolic myocardial infarction
AF suppression by ablation to improve MR/TR
Interventions to reduce MR/TR (MitraClip,
annuloplasty)
 
 

Leave a Comment